DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell S. et al.
Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: A multicentre, multicohort, single-arm phase 2 trial.
Lancet Oncol 2016;
17: 1283-94
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.